Browsing eNauka
Browsing by Author Ciuleanu, Tudor E
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2020 | Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis | Cufer, Tanja; Ciuleanu, Tudor E; Berzinec, Peter; Galffy, Gabriela; Jakopovic, Marko; Jassem, Jacek; Jovanovic, Dragana D; Mihaylova, Zhasmina; Ostoros, Gyula; Thallinger, Christiane;
Zemanova, Milada; Zielinski, Christoph;
| Article | 21M21 |
| 2015 | Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial | Thatcher, Nick; Hirsch, Fred R; Luft, Alexander V; Szczesna, Aleksandra; Ciuleanu, Tudor E; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K; Bálint, Beatrix; Losonczy, György;
Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Kruljac-Letunic, Anamarija; Kurek, Raffael; Paz-Ares, Luis; Socinski, Mark A;
| Article | 21aM21a |
| 2017 | Phase 3 Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, with Docetaxel versus Docetaxel in Advanced Non-Small Cell Lung Cancer (GALAXY-2) | Pillai, Rathi N; Fennell, Dean; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Perin, Branislav M; Yalcin, Ilker; Teofilovici, Florentina;
Vukovic, Vojo M; Ramalingam, Suresh S;
| Conference Paper | Mp. category will be shown later |
| 2010 | Randomized phase III study (SPEAR) of picoplatin plus best supportive care (BSC) or BSC alone in patients (pts) with SCLC refractory or progressive within 6 months after first-line platinum-based chemotherapy. | Ciuleanu, Tudor E; Samarzjia, M; Demidchik, Y; Beliakouski, V; Rancic, M; Bentsion, DL; Orlov, SV; Schaeffier, BA; De, Jager RL; Breitz, HB | Conference Paper | Mp. category will be shown later |
| 2020 | Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non?Small-Cell Lung Cancer (GALAXY-2) | Pillai, Rathi N; Fennell, Dean A; Kovcin, Vladimir N; Ciuleanu, Tudor E; Ramlau, Rodryg; Kowalski, Dariusz; Schenker, Michael; Yalcin, Ilker; Teofilovici, Florentina; Vukovic, Vojo M;
Ramalingam, Suresh S;
| Article | 21aM21a |